The protease-activated Cas9 enzymes could reduce off-target effects and could be used to sense pathogens and trigger an immune response.
The partners will work to find novel proteins, including DNA endonucleases, to develop new gene editing therapies for cystic fibrosis and other diseases.
An Associated Press poll finds that most US adults think it would be fine to use gene editing to prevent an incurable or fatal disease.
The Los Angeles Times says CRISPR gene editing is a field to watch in the next year.
Ohio State University researchers found that a phosphorothioate-modified DNA-crRNA duplex completely blocked the function of Cas12a.
The firm is developing and beta-testing a line of guide RNA libraries to support CRISPR-based targeted capture and sequencing approaches.
In Nature this week: extension to uncultivated virus genome reporting standards, multiplex orthogonal CRISPR-based genome editing approach, and more.
The Washington Post reports on uncertainties facing gene-edited livestock endeavors.
The company, which had raised $55.5 million in February, said its investors have agreed to contribute an additional $30 million.
In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.
An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.
In Science this week: reduction in bee phylogenetic diversity, and more.
The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.